Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
AMD Challenges Nvidia in Korea with Potential 10,000-Chip Deal
US Open: Wall Street on a Geopolitical Rollercoaster
SAP loses 4% despite positive recommendation at Bernstein 📉
Ryanair at 5-month low 🚩Jet fuel price surge pressures aerospace industry